Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
about
Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsNucleic acid aptamers: an emerging frontier in cancer therapyMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateThe Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature ReviewRecent Advances of Light-Mediated Theranostics.Aptamer-Drug ConjugatesSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications.Molecular plasmonics for biology and nanomedicine.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyPhotosensitizer-gold nanorod composite for targeted multimodal therapy.Gold-Coated Fe3O4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging and Therapy.Reduced graphene oxide functionalized with a luminescent rare-earth complex for the tracking and photothermal killing of drug-resistant bacteria.Aptamers: active targeting ligands for cancer diagnosis and therapyMultifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.Multifunctional Hybrid Fe2O3-Au Nanoparticles for Efficient Plasmonic Heating.Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapyLight-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy.Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics.Shape-changing polymer assemblies.Gold nanoparticle conjugates: recent advances toward clinical applications.Targeted nanoparticles for pediatric leukemia therapy.Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics.Gold nanoparticles for photothermally controlled drug release.Nucleic acid aptamers in cancer research, diagnosis and therapy.Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cellsAptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Functional nanomaterials for near-infrared-triggered cancer therapy.Photoactivated drug delivery and bioimaging.CPMV-induced synthesis of hollow mesoporous SiO2 nanocapsules with excellent performance in drug delivery.Optimization of Nanoparticle-Based SERS Substrates through Large-Scale Realistic Simulations.DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics.Aptamers as Therapeutics.Photolabile plasmonic vesicles assembled from amphiphilic gold nanoparticles for remote-controlled traceable drug delivery.Photosensitizer-incorporated G-quadruplex DNA-functionalized magnetofluorescent nanoparticles for targeted magnetic resonance/fluorescence multimodal imaging and subsequent photodynamic therapy of cancer.Targeted Magnetic Nanotheranostics of Cancer.In Vivo Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field.Aptamers as both drugs and drug-carriers.
P2860
Q26752263-6C7DCEDE-6A87-4BDE-B3AB-F3F5574EB117Q26782485-8F95B526-6820-45CC-ABA3-CA36D2F2F4AAQ26849947-7E2A6030-6574-44A4-9339-C74E0524135BQ27011598-0F2ACB22-CBC0-48F2-9596-DC213D52FC3FQ28066827-6CA8B879-E473-44E7-9904-E6B2B7CC828DQ28075327-4C459B77-A4C5-4426-9488-0069EE5E4FD6Q28077517-2CA7458D-224F-4162-B00C-B97E3D7FB48BQ28468281-7E779334-5A98-4BC2-B76A-2497191CEB5FQ30361646-49869AB0-38E7-473D-90C0-CEE19EA5E552Q30402936-7BB0CEB5-AFBD-4065-8215-3650A10CBCC1Q30439956-ACF5450C-C575-40A3-AD45-33300DA1823BQ33834772-EC12E206-2222-4049-AA1C-3040F5516FA9Q34049873-056454A7-A7EC-4C51-BA7D-62D650D69522Q34703015-95107197-20B7-46E6-93EC-95F2B39ED374Q35064755-FF437EE7-B7D4-4347-82C8-E1F525C27A56Q35086493-099F5C29-5439-4F35-8738-78368F49CEB7Q35762630-5D6C829D-05F6-4A2F-A6AB-EA54C8DB31BEQ35953890-24999CC3-18B7-43FD-B49F-1DC3D395DB08Q36124916-D5D01224-B583-45AF-B45B-5FC06B1187A9Q36854187-75530188-D936-43E7-80A5-83D082F7246BQ36855129-B281C522-FC82-468C-A474-52275188CAF3Q38117061-E2A99461-8207-43A4-A926-C44EE6390816Q38190087-CD7BEB63-6369-4574-8F9B-0CF8C70A9E67Q38214772-78A77C82-143A-4490-9658-8F98F0E4BE0DQ38222448-DE70AC2A-BB3B-43BB-BCA9-31C87DD7CEFEQ38262549-C6D0F49A-D6EB-4B4E-8B19-B850EB33FCE3Q38308357-CBC066FA-00D1-4004-95A8-31EEF7ECB9D3Q38326261-D1AE40CF-D6F9-4EDA-A0B1-D52665401ACAQ38491805-AFA4ECD9-8656-411B-8549-06D725C692ADQ38772208-F79B4E24-6149-4388-92DF-8ED40C4C7EAEQ38812224-B51451ED-1BEC-4EE9-A25B-14AAE3E5D052Q38914242-72A3F682-3EA3-4890-AB20-6D1B5CDB42ADQ38940697-BBA8AD01-DDEF-4C4F-8E03-D9F7C4F53D88Q38989650-F69CD5B4-1F22-4245-B23F-982609982AEFQ39070782-DA45E097-B9A9-4E74-8945-44AA94048897Q39149497-C73FDDEF-F563-40E0-8553-039F6C2EFE49Q39343338-143B7715-387A-4FF9-B281-8609939DCC9BQ39366606-38430CD2-BEBE-4CF1-A7C7-D65A1FD0A3A8Q41239491-D0EF923C-D3AE-44AD-ABF6-C1939C1155E0Q42236644-5224E17A-37B8-4819-87BC-CF9CDFADC9C2
P2860
Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Release of photoactivatable dr ...... s for targeted cancer therapy.
@ast
Release of photoactivatable dr ...... s for targeted cancer therapy.
@en
Release of photoactivatable dr ...... s for targeted cancer therapy.
@nl
type
label
Release of photoactivatable dr ...... s for targeted cancer therapy.
@ast
Release of photoactivatable dr ...... s for targeted cancer therapy.
@en
Release of photoactivatable dr ...... s for targeted cancer therapy.
@nl
prefLabel
Release of photoactivatable dr ...... s for targeted cancer therapy.
@ast
Release of photoactivatable dr ...... s for targeted cancer therapy.
@en
Release of photoactivatable dr ...... s for targeted cancer therapy.
@nl
P2093
P356
P1433
P1476
Release of photoactivatable dr ...... s for targeted cancer therapy.
@en
P2093
Yi-Syun Shiao
Yu-Fen Huang
Yun-Ling Luo
P304
P356
10.1021/NN201592S
P407
P577
2011-10-03T00:00:00Z